LYON, France--(BUSINESS WIRE)--Flamel Technologies (Nasdaq: FLML) today announced its financial results for the first quarter of 2007.
Flamel’s revenues during the quarter included the first royalties received from GlaxoSmithKline (NYSE: GSK) on sales of COREG CR, which was launched on March 22nd.
